FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2001489721> ?p ?o ?g. }

• W2001489721 endingPage "362" @default.
• W2001489721 startingPage "355" @default.
• W2001489721 abstract "In epineurial arterioles, acetylcholine-mediated vascular relaxation is mediated by nitric oxide and endothelium-derived hyperpolarizing factor (EDHF), and both mechanisms are impaired by diabetes. The mediator responsible for the effect of EDHF is unknown. In epineurial arterioles, C-type natriuretic peptide (CNP) has properties consistent with EDHF-like activity. Epineurial arterioles express CNP, and exogenous CNP causes a concentration-dependent vascular relaxation. In streptozotocin-induced diabetic rats, CNP-mediated vascular relaxation in epineurial arterioles is decreased. Since CNP may be a regulator of vascular function, a vasopeptidase inhibitor may be an effective treatment for diabetes-induced vascular and neural disease. Vasopeptidase inhibitors inhibit ACE activity and neutral endopeptidase, which degrades natriuretic peptides. Streptozotocin-induced diabetic rats were treated with AVE7688 (450 mg/kg in the diet), a vasopeptidase inhibitor, for 8–10 weeks after 4 weeks of untreated diabetes. Treatment of diabetic rats corrected the diabetes-induced decrease in endoneurial blood flow, significantly improved motor and sensory nerve conduction velocity, prevented the development of hypoalgesia in the hind paw, and reduced superoxide and nitrotyrosine levels in epineurial arterioles. The diabetes-induced decrease in acetylcholine-mediated vascular relaxation by epineurial arterioles was significantly improved with treatment. These studies suggest that vasopeptidase inhibitors may be an effective approach for the treatment of diabetic vascular and neural dysfunction." @default.
• W2001489721 created "2016-06-24" @default.
• W2001489721 creator A5021087036 @default.
• W2001489721 creator A5034151735 @default.
• W2001489721 creator A5046144228 @default.
• W2001489721 creator A5051924004 @default.
• W2001489721 creator A5082694775 @default.
• W2001489721 date "2007-02-01" @default.
• W2001489721 modified "2023-10-11" @default.
• W2001489721 title "Treatment of Streptozotocin-Induced Diabetic Rats With AVE7688, a Vasopeptidase Inhibitor" @default.
• W2001489721 cites W193459508 @default.
• W2001489721 cites W1965178151 @default.
• W2001489721 cites W1978827631 @default.
• W2001489721 cites W1982624356 @default.
• W2001489721 cites W1985109666 @default.
• W2001489721 cites W1987141043 @default.
• W2001489721 cites W2002607374 @default.
• W2001489721 cites W2005362943 @default.
• W2001489721 cites W2005590672 @default.
• W2001489721 cites W2012030770 @default.
• W2001489721 cites W2014889630 @default.
• W2001489721 cites W2016947895 @default.
• W2001489721 cites W2020292584 @default.
• W2001489721 cites W2021840860 @default.
• W2001489721 cites W2024190844 @default.
• W2001489721 cites W2026712832 @default.
• W2001489721 cites W2027127137 @default.
• W2001489721 cites W2027752114 @default.
• W2001489721 cites W2033378879 @default.
• W2001489721 cites W2037177246 @default.
• W2001489721 cites W2038250511 @default.
• W2001489721 cites W2038689608 @default.
• W2001489721 cites W2045232429 @default.
• W2001489721 cites W2045890927 @default.
• W2001489721 cites W2047157458 @default.
• W2001489721 cites W2052336470 @default.
• W2001489721 cites W2071215057 @default.
• W2001489721 cites W2074862244 @default.
• W2001489721 cites W2076142664 @default.
• W2001489721 cites W2076339831 @default.
• W2001489721 cites W2084588606 @default.
• W2001489721 cites W2089972785 @default.
• W2001489721 cites W2091529445 @default.
• W2001489721 cites W2093595574 @default.
• W2001489721 cites W2099642241 @default.
• W2001489721 cites W2102751959 @default.
• W2001489721 cites W2117200096 @default.
• W2001489721 cites W2118233088 @default.
• W2001489721 cites W2122414904 @default.
• W2001489721 cites W2129860928 @default.
• W2001489721 cites W2131840341 @default.
• W2001489721 cites W2140708403 @default.
• W2001489721 cites W2144138736 @default.
• W2001489721 cites W2144798177 @default.
• W2001489721 cites W2147294760 @default.
• W2001489721 cites W2149714579 @default.
• W2001489721 cites W2150346787 @default.
• W2001489721 cites W2181446882 @default.
• W2001489721 cites W2414611100 @default.
• W2001489721 doi "https://doi.org/10.2337/db06-1180" @default.
• W2001489721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17259379" @default.
• W2001489721 hasPublicationYear "2007" @default.
• W2001489721 type Work @default.
• W2001489721 sameAs 2001489721 @default.
• W2001489721 citedByCount "39" @default.
• W2001489721 countsByYear W20014897212012 @default.
• W2001489721 countsByYear W20014897212013 @default.
• W2001489721 countsByYear W20014897212014 @default.
• W2001489721 countsByYear W20014897212015 @default.
• W2001489721 countsByYear W20014897212016 @default.
• W2001489721 countsByYear W20014897212017 @default.
• W2001489721 countsByYear W20014897212018 @default.
• W2001489721 countsByYear W20014897212019 @default.
• W2001489721 countsByYear W20014897212021 @default.
• W2001489721 countsByYear W20014897212022 @default.
• W2001489721 countsByYear W20014897212023 @default.
• W2001489721 crossrefType "journal-article" @default.
• W2001489721 hasAuthorship W2001489721A5021087036 @default.
• W2001489721 hasAuthorship W2001489721A5034151735 @default.
• W2001489721 hasAuthorship W2001489721A5046144228 @default.
• W2001489721 hasAuthorship W2001489721A5051924004 @default.
• W2001489721 hasAuthorship W2001489721A5082694775 @default.
• W2001489721 hasBestOaLocation W20014897211 @default.
• W2001489721 hasConcept C126322002 @default.
• W2001489721 hasConcept C134018914 @default.
• W2001489721 hasConcept C2775910092 @default.
• W2001489721 hasConcept C2776992346 @default.
• W2001489721 hasConcept C2779280383 @default.
• W2001489721 hasConcept C2780972559 @default.
• W2001489721 hasConcept C519581460 @default.
• W2001489721 hasConcept C555293320 @default.
• W2001489721 hasConcept C71924100 @default.
• W2001489721 hasConcept C98274493 @default.
• W2001489721 hasConceptScore W2001489721C126322002 @default.
• W2001489721 hasConceptScore W2001489721C134018914 @default.
• W2001489721 hasConceptScore W2001489721C2775910092 @default.
• W2001489721 hasConceptScore W2001489721C2776992346 @default.
• W2001489721 hasConceptScore W2001489721C2779280383 @default.

• next